back to US directory
us clinical guidance

Palpitations and suspected supraventricular tachycardia

US rhythm documentation, stability assessment, targeted monitoring and management principles for palpitations and adult SVT.

JurisdictionUnited States
Source check2026-08-20
Clinical reviewiatroX editorial team 路 Clinical editorial review 路 reviewed 2026-08-20 路 due 2027-08-20
AudienceUnited States healthcare professionals
This is an iatroX educational summary of named United States sources, not an official guideline. It does not replace the complete source documents, local policy, specialist advice or clinical judgement. Use the named authority, current FDA labeling, applicable state law, payer rules and local protocol where relevant.

Scope of this summary

Adults with intermittent palpitations or documented supraventricular tachycardia, including atrioventricular nodal reentrant tachycardia, atrioventricular reentrant tachycardia and focal atrial tachycardia. Atrial fibrillation has its own 2023 guideline; ventricular tachycardia, pregnancy, pediatrics and congenital heart disease require additional sources.
sources for this section:ACC/AHA/HRS SVT 2015ACC/AHA AF 2023

The Bottom Line

  • Establish hemodynamic stability and capture a diagnostic 12-lead ECG during symptoms whenever possible; a normal resting tracing between episodes does not exclude SVT.
  • Match ambulatory monitoring duration to event frequency and use symptom鈥搑hythm correlation before assigning a chronic arrhythmia diagnosis.
  • For stable regular narrow-complex tachycardia, vagal maneuvers and supervised adenosine are acute options in the guideline; unstable tachycardia requires synchronized cardioversion.
  • Discuss observation, medicine and electrophysiology study with catheter ablation from arrhythmia mechanism, symptom burden, risk and patient preference.
  • Avoid nonspecific reassurance when palpitations accompany syncope, exertion, structural heart disease, inherited arrhythmia or a family history of sudden death.
sources for this section:ACC/AHA/HRS SVT 2015ACC/AHA AF 2023

Practical clinical workflow

1
Characterize onset and offset, regularity, duration, triggers, syncope, exertion, chest symptoms, stimulant or drug exposure, pregnancy and family history.
2
Perform cardiovascular examination and 12-lead ECG; obtain targeted laboratory or cardiac imaging tests only when the history, ECG or comorbidity supports them.
3
Select a Holter, patch, event monitor or implantable monitor based on event frequency, severity and the need to establish symptom鈥搑hythm correlation.
4
For documented SVT, define the mechanism where possible, teach safe vagal maneuvers and discuss drug versus ablation options with electrophysiology.
5
Document emergency instructions and follow-up for symptom recurrence, treatment response and procedure outcomes.
sources for this section:ACC/AHA/HRS SVT 2015ACC/AHA AF 2023

Safety boundaries and escalation

  • Hypotension, ischemic chest discomfort, acute heart failure, altered mental status or shock attributable to tachycardia requires immediate synchronized cardioversion.
  • A wide-complex or irregular pre-excited rhythm should not be treated as routine narrow-complex SVT; obtain emergency expert management.
  • Review conduction disease, ventricular function, pregnancy, kidney or liver function and interactions before chronic antiarrhythmic or AV-nodal-blocking therapy.
  • Palpitations with exertional syncope, inherited-arrhythmia features or family sudden death warrant expedited specialist evaluation.
sources for this section:ACC/AHA/HRS SVT 2015ACC/AHA AF 2023

Localization

Use the ACC/AHA/HRS adult SVT guideline, US emergency protocols and FDA labeling. State driving restrictions and insurer coverage for monitors or ablation may vary.
sources for this section:ACC/AHA/HRS SVT 2015ACC/AHA AF 2023

Source documents

Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.

  1. American College of Cardiology, American Heart Association, and Heart Rhythm Society2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular TachycardiaDOI 10.1161/CIR.0000000000000311 路 published 2015-09-23 路 accessed 2026-08-20
    view source
  2. American College of Cardiology and American Heart Association Joint Committee on Clinical Practice Guidelines2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial FibrillationDOI 10.1161/CIR.0000000000001193 路 published 2023-11-30 路 accessed 2026-08-20
    view source
continue the learning

From guidance to deliberate practice and evidence

Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.

Add this guidance review to CPD/CMEOpen an editable learning-log record with this page鈥檚 provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what鈥攊f anything鈥攜ou may change. Suggestions are never inserted automatically.Browse the US question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.